Senior Mobile App Engineer, Beacon Biosignals

React Native/iOS/Android

Salary not provided

React

TypeScript

React Native

GraphQL

iOS

Android

Senior and Expert level

Boston

New York

Remote from US

More information about location

AI brain monitoring

Posted today

AI brain monitoring

21-100 employees

HealthcareB2BArtificial IntelligenceMachine LearningMedTech

Posted today

Salary not provided

React

TypeScript

React Native

GraphQL

iOS

Android

Senior and Expert level

Boston

New York

Remote from US

More information about location

21-100 employees

HealthcareB2BArtificial IntelligenceMachine LearningMedTech

Company mission

To improve human health by enabling rapid, targeted interventions through advanced brain analytics.

Job

Company

Role

Who you are

You have at least 8 years of mobile app development experience
You have real-world experience developing cross-platform with TypeScript and React Native, as well as writing native code for iOS and/or Android
You have experience integrating BLE peripheral devices with both iOS and Android applications
You've built and maintained mobile applications backed by GraphQL APIs and data streaming services. You're well-acquainted with the intersection of backend data lifecycles and frontend data lifecycles, and that intersection's impact on end users
You have experience developing mobile applications that function well even in poor network conditions
You know what a well designed mobile application looks like, including first-class CI/CD/tools, and how much friction poorly designed tools/systems can introduce into the development cycle

What the job involves

Beacon Biosignals is seeking an experienced Senior Mobile App Engineer to help develop the mobile companion apps for Beacon's wearable biosensors. These apps play a vital role in our mission to enable scalable brain health monitoring and accelerate precision medicine for millions of people living with neurological and psychiatric conditions
You partner with our Hardware team, Platform teams, and Product to develop user-centric mobile app capabilities that are deeply integrated with the rest of Beacon’s product ecosystem
You leverage feedback from real users in a myriad of target clinical trial environments and other usage scenarios to optimize the user experience across the range of use cases
You build an expertly-designed product that unlocks brain health monitoring capabilities that are unprecedented with regards to accessibility, longitudinality, and robustness

Our take

The brain has long been considered one of the most mysterious fields of medicine - and psychiatric and neurological diseases therefore one of the least understood. Better access to real-time brain data, however, could change this. That’s exactly what Beacon Biosignals is hoping to deliver.

Beacon Biosignals has developed a scaleable electroencephalogram (EEG) analytics platform that leverages AI to more accurately and insightfully manage brain data. Its capabilities run from analysing existing data, to identifying and standardizing neorobiomarkers, to continuously aggregating and analyzing trial data.

The hope is that this will help clinical brain researchers carry out faster and more accurate work, ultimately accelerating the pace of treatment development in neurology. It’s a smart new AI application, and Beacon Biosignals is acquiring new companies to scale and receiving handsome funding - but for that reason the company isn’t alone in pursuing it. Bitbrain is also developing neurology AI, although with a tighter focus on product development. This may help differentiate Beacon Biosignals in what is still a relatively new market area.

Kirsty

Company Specialist at Welcome to the Jungle

Insights

40% employee growth in 12 months

Glassdoor (4.3)

Company

Funding (last 2 of 3 rounds)

Nov 2021

$27m

SERIES A

Jun 2019

$3m

SEED

Total funding: $30.5m

Company HQ

Beacon Hill, Boston, MA

Leadership

Jarrett Revels

(CTO)

Previously a Software Engineer at MissionFocus, who then moved into various engineering and research roles at MIT.

Jacob Donoghue

(CEO)

Completed a Neuroscience PhD at MIT, and received his MD from Harvard Medical School. Subsequently carried out research for Cyberkinetics Neurotechnology Systems and Massachusetts General Hospital.

Brandon Westover

(Co-founder)

Received his MD from Washington University School of Medicine, then took up a Neurology residency at Harvard Medical School. Alongside his work at Beacon Biosignals, is also an HST Faculty member at MIT and a Neurologist/Medical AI Researcher at Massachusetts General Hospital.

Syd Cash

(Co-founder)

An Associate Professor at Harvard Medical School, who also leads the Center for Neurotechnology and Neurorecovery at MGH.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job